12:00 AM
Dec 23, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Innate Immunotherapeutics completes IPO

Innate Immunotherapeutics Ltd. (ASX:IIL), Auckland, New Zealand
Business: Autoimmune, Cancer, Infectious

Read the full 36 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >